Chirag P Shah1, David Rhee, Sunir J Garg. 1. *Ophthalmic Consultants of Boston, Boston, Massachusetts †MidAtlantic Retina, The Retina Service of Wills Eye Institute, Thomas Jefferson University, Philadelphia, Pennsylvania.
Abstract
BACKGROUND: Cutaneous hypopigmentation has been reported after steroid injection. Sub-Tenon triamcinolone injection is often administered to control or prevent ocular inflammation. METHODS: Observational case report. RESULTS: Lower eyelid cutaneous hypopigmentation developed 6 weeks after sub-Tenon triamcinolone injection administered at the conclusion of scleral buckle and vitrectomy for retinal detachment repair. The hypopigmentation eventually resolved at 7 months postoperatively. CONCLUSION: Sub-Tenon triamcinolone injection at the conclusion of retinal surgery can cause temporary cutaneous hypopigmentation of the eyelid. This risk should be explained preoperatively to patients, particularly those who are more heavily pigmented.
BACKGROUND:Cutaneous hypopigmentation has been reported after steroid injection. Sub-Tenon triamcinolone injection is often administered to control or prevent ocular inflammation. METHODS: Observational case report. RESULTS: Lower eyelid cutaneous hypopigmentation developed 6 weeks after sub-Tenon triamcinolone injection administered at the conclusion of scleral buckle and vitrectomy for retinal detachment repair. The hypopigmentation eventually resolved at 7 months postoperatively. CONCLUSION: Sub-Tenon triamcinolone injection at the conclusion of retinal surgery can cause temporary cutaneous hypopigmentation of the eyelid. This risk should be explained preoperatively to patients, particularly those who are more heavily pigmented.